西隴科學(002584.SZ)上半年淨利7594.63萬元,同比下降42.35%
格隆匯8月14日丨西隴科學(002584.SZ)披露2022年半年度報吿,報吿期內,公司實現營業收入34.23億元,同比增長5.91%;歸屬於上市公司股東的淨利潤7594.63萬元,同比下降42.35%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1151.85萬元,同比下降46.39%;基本每股收益0.13元。
報吿期內,完成了山東艾克韋生物技術有限公司60%股權轉讓事項。公司積極拓展新能源領域業務佈局,收購了新泰市盈和新能源材料有限公司100%股權,新泰盈和主要從事磷酸鐵鋰正極材料的研發、生產和銷售。公司在收購的同時投資設立了雲南盈和新能源材料有限公司,開展年產5萬噸磷酸鐵鋰電池正極材料項目建設。
報吿期內,原油出現利空預期,石油產業鏈上的化工品價格出現下滑趨勢,化工原料業務受到影響。公司緊密跟蹤下游半導體、光伏太陽能、LED、平板顯示和鋰電池等行業需求變化,聚焦市場結構,以細分市場為基礎,通過合理的產品規劃,優化產品結構,調整產品價格,實現了化學試劑業務的穩定銷售,最終實現營業收入的增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.